iShares LifePath Target Date 2040 ETF (NYSEARCA:ITDD – Get Free Report) was the recipient of a significant increase in short interest in August. As of August 31st, there was short interest totaling 29,702 shares, an increase of 128.0% from the August 15th total of 13,027 shares. Approximately 1.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 14,450 shares, the short-interest ratio is presently 2.1 days.
iShares LifePath Target Date 2040 ETF Stock Performance
Shares of ITDD stock opened at $38.80 on Monday. iShares LifePath Target Date 2040 ETF has a 52 week low of $34.08 and a 52 week high of $39.47. The stock has a market capitalization of $105.54 million, a PE ratio of 20.77 and a beta of 0.73. The stock’s fifty day moving average is $38.75 and its 200-day moving average is $37.62.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in ITDD. Sunbelt Securities Inc. acquired a new position in shares of iShares LifePath Target Date 2040 ETF during the 3rd quarter worth about $79,000. Bellwether Advisors LLC acquired a new position in shares of iShares LifePath Target Date 2040 ETF in the 4th quarter valued at $249,000. Finally, Jane Street Group LLC acquired a new stake in iShares LifePath Target Date 2040 ETF during the 4th quarter worth $638,000.
iShares LifePath Target Date 2040 ETF Company Profile
The iShares LifePath Target Date 2040 ETF (ITDD) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2040 ITDD was launched on Oct 17, 2023 and is issued by BlackRock.
Further Reading
- Five stocks we like better than iShares LifePath Target Date 2040 ETF
- Smart Money Shifts: U.S. Bancorp Pairs Tech With Yield
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
Receive News & Ratings for iShares LifePath Target Date 2040 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2040 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
